ELIZABETH GAFFORD: Open Payments
NPI 1477320620 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$619 in 29 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $870 · 2025 $619
Food & beverage: $619
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 7 | $166 |
| PFIZER INC. | 4 | $94 |
| Novo Nordisk Inc | 4 | $78 |
| Gilead Sciences, Inc. | 2 | $67 |
| Lilly USA, LLC | 4 | $60 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Exact Sciences Corporation | 2 | $34 |
| Merck Sharp & Dohme LLC | 1 | $29 |
| Dexcom, Inc. | 1 | $20 |
| SANOFI-AVENTIS U.S. LLC | 1 | $17 |
Products named: DOVATO, APRETUDE, NURTEC ODT, Ozempic, MOUNJARO, PIFELTRO, Dexcom G6 Transmitter, PREVNAR 20.
Industry payments across GA — which companies pay providers there.
